IRISanRaf

BARBANTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.920
AS - Asia 3.634
EU - Europa 1.295
SA - Sud America 469
Continente sconosciuto - Info sul continente non disponibili 299
AF - Africa 81
OC - Oceania 13
Totale 11.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.373
TR - Turchia 1.061
SG - Singapore 926
CN - Cina 753
IT - Italia 647
CA - Canada 483
BR - Brasile 353
VN - Vietnam 284
BD - Bangladesh 166
IN - India 96
HK - Hong Kong 94
FR - Francia 92
DE - Germania 90
GB - Regno Unito 79
IE - Irlanda 73
UA - Ucraina 72
EU - Europa 65
PK - Pakistan 59
RU - Federazione Russa 58
AR - Argentina 43
ID - Indonesia 37
IL - Israele 37
FI - Finlandia 36
NL - Olanda 34
ES - Italia 26
MX - Messico 25
EC - Ecuador 18
CO - Colombia 17
ZA - Sudafrica 17
SC - Seychelles 16
JP - Giappone 15
SE - Svezia 15
IQ - Iraq 14
MY - Malesia 14
PL - Polonia 14
VE - Venezuela 14
PH - Filippine 12
KE - Kenya 11
AU - Australia 10
CL - Cile 8
CR - Costa Rica 8
EG - Egitto 8
KZ - Kazakistan 8
CH - Svizzera 7
PY - Paraguay 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
MA - Marocco 6
NP - Nepal 6
RO - Romania 6
TN - Tunisia 6
UZ - Uzbekistan 6
IR - Iran 5
KR - Corea 5
PT - Portogallo 5
RS - Serbia 5
TW - Taiwan 5
DK - Danimarca 4
JO - Giordania 4
MD - Moldavia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
BB - Barbados 3
BO - Bolivia 3
GT - Guatemala 3
HN - Honduras 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BE - Belgio 2
BG - Bulgaria 2
BS - Bahamas 2
BW - Botswana 2
CU - Cuba 2
ET - Etiopia 2
HR - Croazia 2
JM - Giamaica 2
LB - Libano 2
LT - Lituania 2
LY - Libia 2
MN - Mongolia 2
MT - Malta 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
Totale 11.465
Salva come PNG Salva come JPEG
Città #
Kocaeli 926
San Mateo 664
Dallas 632
San Jose 601
Ashburn 518
Toronto 427
Rome 383
Council Bluffs 368
Singapore 282
Santa Clara 236
Beijing 224
Wilmington 223
Phoenix 197
Houston 183
Princeton 152
Lawrence 140
Ho Chi Minh City 115
Hong Kong 90
Los Angeles 81
Fairfield 74
New York 64
Seattle 61
Hanoi 54
Chandler 49
São Paulo 47
West Jordan 46
Islamabad 45
Redwood City 43
Shanghai 43
Frankfurt am Main 41
Woodbridge 34
Brooklyn 32
Milan 31
Netanya 31
Cambridge 26
Guangzhou 26
Helsinki 26
Dublin 25
Montreal 20
Chicago 18
Jakarta 15
Mexico City 15
Orem 15
Boston 13
Shenzhen 13
Vicenza 13
Amsterdam 12
Haiphong 11
Kuala Selangor 11
London 11
Miami 11
Munich 11
Rio de Janeiro 11
Tokyo 11
Abbeville 10
Atlanta 10
Buffalo 10
Denver 10
Nairobi 10
Philadelphia 10
Suffern 10
Charlotte 9
Naples 9
Washington 9
Florence 8
Las Vegas 8
Saint Petersburg 8
San Francisco 8
Turin 8
Andover 7
Biên Hòa 7
Chennai 7
Curitiba 7
Da Nang 7
Dhaka 7
Johannesburg 7
Mumbai 7
Quito 7
Roubaix 7
Rui'an 7
San José 7
Secaucus 7
The Dalles 7
Turku 7
Wuhan 7
Almaty 6
Ankara 6
Bexley 6
Ha Long 6
Kansas City 6
Manchester 6
Pune 6
St Petersburg 6
Warsaw 6
Wroclaw 6
Wuxi 6
Ann Arbor 5
Belo Horizonte 5
Boardman 5
Bologna 5
Totale 7.786
Salva come PNG Salva come JPEG
Nome #
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 362
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine 143
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 142
Amitriptyline in preventive treatment of tension headaches in non-depressed patients is efficient for chronic, but not for episodic cases 139
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 135
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease 125
A case-control study on excessive daytime sleepiness in chronic migraine 111
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 110
A case-control study on excessive daytime sleepiness in chronic migraine 108
A case - control study on excessive daytime sleepiness in episodic migraine 106
A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine 104
Open-label Pilot Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Menstrual Migraine and Menstrually Related Migraine 99
Prolonged muscular flaccidity after stroke morphological and functional brain alterations 98
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 97
Ketogenic diet in migraine: rationale, findings and perspectives 93
Clinical features, disease progresson and use of healthcare resoiurces in a large sample of 866 patients from 24 headaches centers: a real-life perspective from the italian chronic migraiNE (IRON) project 93
A mechanism-based classification of pain in multiple sclerosis 91
Hypertension as a risk factor for migraine chronification 88
Amitriptyline is effective in chronic but not in episodic tension-type headache: Pathogenetic implications 87
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 86
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation) 86
Acupuncture in cluster headache: Four cases and review of the literature 86
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study 84
Migraine attack delays gastric emptying: an ultrasonographic study 83
Prolonged muscular flaccidity: frequency and association with unilateral spatial neglect after stroke 83
Early (<= 1-h) vs. late (> 1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study 82
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 82
Restless legs syndrome is not associated with migraine with aura: a clinical study 81
Future trends in drugs for migraine prophylaxis 81
Unilateral cranial autonomic symptoms in migraine 80
Dopamine hypersensitivity in migraine: Role of the apomorphine test 80
Treatment of tension-type headache: from old myths to modern concepts 80
Acute pathological laughter induced by sumatriptan 78
Association of 24-h productivity with 2-h pain-free rates following administration of a fast disintegrating/rapid release formulation of sumatriptan 78
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study 78
Pharmacotherapy for acute migraines in children and adolescents 77
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 76
Prolonged muscular flaccidity in stroke patients is associated with crossed cerebellar diaschisis 76
Machine learning approach to predict medication overuse in migraine patients 76
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 75
Migraine as a Cortical Brain Disorder 75
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial 74
Tardive dyskinesias in the elderly 74
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 74
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease 73
Late motor recovery is influenced by muscle tone changes after stroke 72
Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes 72
Dopamine and migraine: does Parkinson's disease modify the course of migraine? 72
Migraine and Tourette syndrome 72
Dopamine and migraine: Does Parkinson's disease modify migraine course? 72
Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinic 72
Cluster headache: management of acute attacks before triptans 71
Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based Study 71
A proposal for a national registry on chronic migraines 71
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 71
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 70
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study 70
Cerebral Transverse Sinus Morphology As Detected by MR Venography in Patients With Chronic Migraine 70
Real-world insights on the management of migraine patients: an Italian nationwide study 70
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 69
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 69
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment 69
Differences in short-term primary motor cortex plasticity as assessed by repetitive transcranial magnetic stimulation in migraine with and without aura 69
Tension type headache: a neuropsychological and neurophysiological study 69
Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations 69
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 69
Association of LTA and SOD Gene Polymorphisms with Cerebral White Matter Hyperintensities in Migraine Patients 68
Donepezil in the treatment of progressive supranuclear palsy 68
Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study 68
NON-INVASIVE VAGUS NERVE STIMULATION (NVNS) FOR THE ACUTE TREATMENT OF MIGRAINE WITHOUT AURA IN ADOLESCENTS: PRELIMINARY CLINICAL EXPERIENCE 68
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura 67
Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine 67
Migraine and movement disorders 67
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study 67
Comparison of frovatriptan plus dexketoprofen (25mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study 66
Migraine prophylaxis: what is new and what we need? 66
The evaluation of difficulties with work-related activities caused by migraine: towards a specific questionnaire 66
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70 65
Erenumab during pregnancy: a case report in a patient with chronic migraine 65
Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test 64
Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana 64
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial 64
Look beyond COMT genotype for cathecolamines derangement in migraine: the biobim rs4818 and rs4680 polymorphisms study 63
Shortened cortical silent period in facial muscles of patients with migraine 63
Dopaminergic symptoms in migraine 63
Chronic migraine: treatability, refractoriness, pseudo-refractoriness 63
Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire 63
Creutzfeldt-Jakob disease and related disorders: Etiopathogenetic aspects 62
Impairment of trigeminal sensory pathways in cluster headache 62
Drugs targeting nitric oxide synthase for migraine treatment 62
Trigeminal sensory pathway function in patients with SUNCT 61
HEADACHE FREQUENCY AND CHARACTERISTICS IN CHRONIC COCAINE USERS: A CROSS SECTIONAL STUDY 61
Efficacy and Safety of Frovatriptan plus Dexketoprofen in Menstrual Related Migraine (MRM) 61
Socio-economic costs of migraine 61
Very-low-calorie ketogenic diet vs hypocaloric balanced diet in the prevention of high-frequency episodic migraine: the EMIKETO randomized, controlled trial 60
Dopaminergic symptoms in migraine: a case series on 446 consecutive patients 60
Increased density of dopamine D-5 receptor in peripheral blood lymphocytes of migraineurs: A masker for migraine? 60
Headache in chronic cocaine users: A cross-sectional study 60
Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel 60
Cocaine and headache: a 2-year follow-up study in chronic cocaine users and literature review 59
Totale 8.032
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022515 0 0 0 6 2 0 103 162 16 200 11 15
2022/2023468 319 8 4 18 16 5 12 16 16 26 22 6
2023/2024387 5 2 9 46 14 52 1 27 0 85 3 143
2024/20251.519 81 221 128 52 86 257 111 107 176 22 39 239
2025/20264.521 259 356 662 381 269 461 521 265 504 446 226 171
2026/20271.330 29 459 612 230 0 0 0 0 0 0 0 0
Totale 11.711